View of Sodium–Glucose Cotransporter-2 (SGLT-2) Inhibitors for Slowing the Progression of Chronic Kidney Disease: A Systematic Review of Randomized Controlled Trials and Primary Studies

Return to Article Details Sodium–Glucose Cotransporter-2 (SGLT-2) Inhibitors for Slowing the Progression of Chronic Kidney Disease: A Systematic Review of Randomized Controlled Trials and Primary Studies Download Download PDF